A Clear Answer to a Common Question
Let’s get straight to the point, as this is a question that weighs heavily on the minds of many. Can your HLA-B27 status change from positive to negative? The direct and scientifically unequivocal answer is no. Your HLA-B27 status is a fundamental part of your genetic code, determined at the moment of conception and remaining constant throughout your entire life. It is as unchangeable as your naturally inherited eye color or blood type.
So, you might be wondering, why does this question even come up so often? The confusion usually stems from the complexities of medical testing and the profound hope for remission or a cure for the autoimmune conditions associated with this biomarker, such as ankylosing spondylitis. This article will take a deep, comprehensive dive into what HLA-B27 actually is, why it’s a permanent genetic marker, and most importantly, explain the real reasons why test results can sometimes appear to change, causing confusion and concern for patients.
Understanding the HLA System and the Role of HLA-B27
To truly grasp why HLA-B27 can’t just disappear, we first need to understand what it is. Imagine your body’s cells each have a unique molecular “ID card” on their surface. This ID card system is known as the Human Leukocyte Antigen (HLA) system. Its primary job is to help your immune system—your body’s security force—distinguish between your own healthy cells (“self”) and foreign invaders like viruses, bacteria, or other pathogens (“non-self”).
These HLA proteins are coded for by a specific group of genes on chromosome 6. There are many different types of HLA genes, leading to a vast diversity of cellular “ID cards” across the human population. This diversity is crucial for our species’ ability to fight off a wide range of diseases.
HLA-B27 is simply one specific type, or variant, of an HLA protein. It’s a Class I HLA molecule, found on the surface of nearly all cells in your body. Being “HLA-B27 positive” means that you inherited the specific gene that codes for the production of this particular protein from one or both of your parents. It’s a part of your genetic blueprint, not something you acquire or can get rid of later in life.
Key Takeaway: HLA-B27 isn’t a disease or a virus. It’s a normal, naturally occurring protein for those who have the gene for it. Its presence is determined by your DNA, making it a fixed genetic marker.
The Unchanging Nature of Our Genes: Why Your HLA-B27 Status is Permanent
Our genetic makeup is the instruction manual for building and operating our bodies. We receive one set of chromosomes (containing our genes) from our mother and one set from our father. The gene for HLA-B27 is passed down in this way. If at least one of your parents carries the gene, you have a chance of inheriting it.
Once this genetic information is locked in at conception, it doesn’t change. You cannot spontaneously develop the HLA-B27 gene if you weren’t born with it, nor can your body “delete” or “cure” itself of a gene it already possesses. Medical treatments, diet, lifestyle changes, or disease remission, while profoundly impactful on your health and symptoms, have absolutely no effect on your underlying genetic code. Your cells will continue to read the DNA instructions they were given and, if the gene is present, will continue to produce the HLA-B27 protein.
Thinking about it this way might help: if you have ankylosing spondylitis and achieve remission, your symptoms of pain and inflammation may vanish, but the underlying genetic predisposition—your HLA-B27 status—remains. It’s a risk factor that is always there, which is why ongoing management and awareness are so important.
Apparent Changes in HLA-B27 Test Results: Unraveling the Mystery
This is the heart of the matter and the source of most confusion. If the gene is permanent, how could someone possibly receive a negative result at one point and a positive result later, or vice versa? The answer lies not in a biological change within the patient, but in the nuances, limitations, and differences of the laboratory tests themselves.
There are two primary methods used to test for HLA-B27, and understanding how they differ is crucial.
The Nuances of Laboratory Testing: Flow Cytometry
This has historically been the most common method for HLA-B27 screening. It’s a test that looks for the actual HLA-B27 protein on the surface of your white blood cells (lymphocytes).
How it works:
- A blood sample is taken.
- The white blood cells are isolated.
- These cells are mixed with specific antibodies that are designed to recognize and bind only to the HLA-B27 protein. These antibodies are tagged with a fluorescent dye.
- The cells are then passed, one by one, through a laser beam in a machine called a flow cytometer.
- If the HLA-B27 protein is present on a cell, the fluorescent antibody will have attached to it, and the cell will “light up” or fluoresce as it passes through the laser. The machine counts how many cells light up.
Why it can lead to inconsistent results:
- Technical Errors: Like any complex lab procedure, things can go wrong. Improper sample handling (e.g., storage at the wrong temperature), expired or faulty reagents (the antibody solution), or a poorly calibrated machine can all lead to an inaccurate result, most often a false negative.
- Low Antigen Expression: This is a key biological factor. Some individuals who have the HLA-B27 gene naturally express a lower-than-average amount of the protein on their cell surfaces. In these cases, there might not be enough protein for the fluorescent antibodies to bind to in sufficient numbers to cross the “positive” threshold set by the lab, resulting in a false negative or an “indeterminate” result.
- Subjective Interpretation: A lab technician has to set a “gate” or a cutoff point on the flow cytometer’s software that defines what is considered a positive versus a negative result. If a person’s result falls right on the borderline, one technician or lab might interpret it as a weak positive, while another might call it negative.
The Gold Standard: Genetic Testing (PCR)
The more modern and definitive method is DNA-based testing, most commonly using a technique called Polymerase Chain Reaction (PCR). This method completely bypasses the potential issues of protein expression because it doesn’t look for the protein at all.
How it works:
Instead of looking for the finished product (the protein), PCR analysis looks directly at your DNA to see if the HLA-B27 gene—the blueprint itself—is present.
- A DNA sample is extracted from your blood or a cheek swab.
- The PCR process finds the specific segment of DNA corresponding to the HLA-B27 gene.
- It then makes millions to billions of copies of that specific segment, amplifying it to a level that is easily detectable.
Why it is more accurate and definitive:
Since PCR looks directly for the gene, it delivers a simple yes-or-no answer. You either have the gene, or you don’t. It is not affected by low protein expression, sample handling issues that might degrade proteins, or the subjective interpretation of a borderline result. A positive PCR test for HLA-B27 is considered conclusive.
So, the most common scenario for an “apparent change” from negative to positive is this: A patient with early symptoms of spondyloarthritis gets a flow cytometry test that comes back negative (likely a false negative due to low protein expression). As their symptoms persist, their rheumatologist, seeking a definitive answer, orders the more accurate PCR test, which comes back positive. It appears the status has changed, but in reality, the first test was simply inaccurate, and the second, more precise test revealed the true, lifelong status.
Human Error and Clerical Mistakes
We shouldn’t overlook the simplest explanation. In any process involving human beings, errors can happen. A mislabeled sample, a data entry error in the lab’s information system, or a mix-up in reporting can all lead to a patient receiving the wrong result. While labs have stringent protocols to prevent this, it remains a remote possibility.
Comparing HLA-B27 Testing Methods: A Side-by-Side Look
To make the differences clearer, here is a table comparing the two main testing methods.
| Feature | Flow Cytometry (Protein-based) | PCR (DNA-based) |
|---|---|---|
| What it Detects | The HLA-B27 protein on the surface of cells. | The HLA-B27 gene within your DNA. |
| Accuracy | High, but susceptible to false negatives and indeterminate results. | Extremely high and considered the “gold standard.” Provides a definitive result. |
| Common Use | Often used as an initial screening test. | Used for confirmation, in cases with unclear symptoms, or when a definitive result is required. |
| Potential for “False Negative” | Moderate, especially in individuals with low protein expression. | Extremely low to virtually none. |
| Can the Result Change? | No, but the test’s interpretation can vary. A result might be negative on one test and positive on another due to lab or biological variables. | No. The presence of the gene is a biological constant. A result from this test is permanent. |
Putting It in Context: The Clinical Significance of Being HLA-B27 Positive
It is critically important to understand what being HLA-B27 positive means—and what it doesn’t mean. Being HLA-B27 positive is NOT a diagnosis of a disease. In fact, the vast majority of people worldwide who are HLA-B27 positive live their entire lives with no related health issues. It is simply a genetic risk factor.
However, it does have a very strong association with a group of autoimmune inflammatory conditions known as spondyloarthropathies. The presence of HLA-B27 is a significant piece of the diagnostic puzzle for a rheumatologist.
Diseases Strongly Associated with HLA-B27:
- Ankylosing Spondylitis (AS): This is the classic association. Approximately 90-95% of Caucasians with AS are HLA-B27 positive. AS primarily causes inflammation in the spine and sacroiliac joints, leading to chronic pain and stiffness.
- Reactive Arthritis: This is arthritis that develops in reaction to an infection elsewhere in the body, typically in the gut or genitourinary tract.
- Psoriatic Arthritis: A form of arthritis that affects some people with the skin condition psoriasis.
- Enteropathic Arthritis: Arthritis that is associated with inflammatory bowel disease (IBD), such as Crohn’s disease or ulcerative colitis.
- Juvenile Idiopathic Arthritis (JIA): Specifically, the enthesitis-related arthritis subtype of JIA is strongly linked to HLA-B27.
- Acute Anterior Uveitis: A painful inflammation of the front part of the eye (the uvea), which can occur on its own or alongside one of the arthritic conditions.
The key here is correlation, not causation. The HLA-B27 gene doesn’t directly cause these diseases. The leading theory is that the structure of the HLA-B27 protein may, in genetically susceptible individuals and often after a triggering event (like an infection), mistakenly present one of the body’s own proteins to the immune system as if it were a foreign invader. This triggers a misguided autoimmune attack, leading to chronic inflammation.
Exploring the Other Side: Could Someone Become HLA-B27 Positive?
Just as you cannot change from positive to negative, the reverse is also impossible. You cannot “become” HLA-B27 positive if you were not born with the gene. Any apparent change from a previous negative result to a new positive one is overwhelmingly likely to be the result of moving from a less sensitive test (flow cytometry) to the definitive gold standard (PCR genetic testing), which corrected an initial false negative.
Final Thoughts: A Constant in Your Genetic Makeup
So, we come full circle to our initial question. The ability for HLA-B27 to change from positive to negative is a medical myth, born from a misunderstanding of genetics and the complexities of lab testing. Your HLA-B27 status is a stable, lifelong part of your genetic identity.
If you have received conflicting test results, it is essential to discuss them with your doctor. It’s not a sign that your biology is changing, but rather a strong indication that a more precise testing method has revealed the true picture. Understanding this can alleviate a great deal of anxiety and help you and your healthcare team focus on what truly matters: managing your symptoms and health.
Knowing your HLA-B27 status is a powerful piece of information. It’s not a verdict or a destiny, but a single clue that, when combined with your symptoms, physical examination, and other imaging or lab tests, helps your doctor make an accurate diagnosis and create the most effective treatment plan for you. It’s a constant factor in your health equation, and understanding its permanence is the first step toward effectively navigating your health journey.